clinical trials

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

clinical trials
Apr 4, 2024, 07:02 | Insight
Tatiana Prowell: Inclusion of patients with brain metastases in your oncology clinical trials
Tatiana Prowell shared on X/Twitter: "Inclusion of patients with brain metastases in your oncology clinical…
Apr 2, 2024, 12:20 | Insight
Ankit Mangla: Our analysis of data from neoadjuvant IO trials in melanoma has been published in JAMA Oncology
Ankit Mangla, Sarcoma and Cutaneous Oncology Specialist at the Seidman Cancer Center, shared a post…
Mar 31, 2024, 09:18 | Blog
Sandy Cassanelli: Reflecting on Taste the Cure 2024, our hearts are filled with inspiration and empowerment
Sandy Cassanelli, the CEO of Greenough Packaging and Maintenance Supplies and Breast Friends Fund-Funding Research…
Mar 29, 2024, 23:06 | Blog
Neil Ranasinghe: So proud to receive the Flames of Hope Honorary Fellowship from Cancer Research UK (CRUK)
Neil Ranasinghe, Lead Technical Author at London Stock Exchange, sharen on LinkedIn: “So proud to…
Mar 29, 2024, 22:45 | Blog
We're beyond thrilled to join forces with Brittney’s Believers Foundation - Oncoheroes Biosciences
Oncoheroes Biosciences made the following post on LinkedIn: "Exciting Announcement! We're beyond thrilled to join…
Mar 29, 2024, 22:30 | Blog
Brendon Stiles: Let's talk about PACIFIC 2
Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology at Montefiore Health System, posted…
Mar 25, 2024, 16:15 | Insight
Piotr Wysocki: Stereotactic ablative body radiotherapy of primary tumor is highly active in patients with localized renal cell cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 25, 2024, 06:33 | Insight
Mohammed Shahait: Our new study exploring female leadership in GU malignancies
Mohammed Shahait, Clinical Instructor of Urology at The University of Pennsylvania and The University of…
Mar 24, 2024, 00:09 | Blog
Vivek Subbiah: Tune in to the podcast for insights into equitable access to cancer clinical trials
Vivek Subbiah posted on LinkedIn “Excited to announce my latest venture! Hosting an interview with…
Mar 22, 2024, 23:32 | Insight
Piotr J. Wysocki: Ribociclib combined with an aromatase inhibitor in the adjuvant treatment of breast cancer – interim analysis of Natalee study
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 22, 2024, 15:57 | Dialogues
OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…
Mar 21, 2024, 16:09 | Insight
Bishal Gyawali: A pleasure to write this editorial with the brilliant Nina Niu Sanford on how to manage FCOI in oncology
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: “Hot…
Mar 20, 2024, 16:16 | Blog
Fred Hirsch: I hope PRAGMATICA study will be a role model for future studies
Fred Hirsch, Executive Director at the Center for Thoracic Oncology at Tisch Cancer Institute, shared…
Mar 18, 2024, 19:11 | Blog
Fredrick Chite Asirwa: International Cancer Institute clinic is recruiting breast cancer patients for clinical trials currently
Fredrick Chite Asirwa, CEO/Executive Director of International Cancer Institute, posted on LinkedIn: "To contribute to…
Mar 17, 2024, 19:55 | Blog
Ishwaria Subbiah: The power of community in action at The US Oncology Network Annual Conference
Ishwaria Subbiah, Medical Director at The US Oncology Network and Executive Director at Sarah Cannon…
Mar 17, 2024, 16:19 | Blog
Sana Al Sukhun: Glad to have contributed to this policy calling for equity in clinical trials
Sana Al Sukhun, Co-Chair of RSG Committee of ASCO for Metastatic Breast Cancer, made the…
Mar 15, 2024, 18:44 | Blog
A new ASCO policy statement is emphasizing the urgent need for global equity in Clinical Trials - American Society of Clinical Oncology
American Society of Clinical Oncology (ASCO) shared on LinkedIn: “A new ASCO policy statement is emphasizing…
Mar 13, 2024, 22:35 | Blog
Ricardo Garcia: Oncoheroes Biosciences stand as a symbol of what can be accomplished when a community unites for a common cause
Ricardo Garcia, CEO and founder of Oncoheroes Biosciences, shared a post by Oncoheroes Biosciences, on…
Mar 11, 2024, 21:03 | Blog
Julie Gralow: Hard at work at the 7th International (CReDO) workshop in Lonavala, India
Julie Gralow shared a post on LinkedIn: “Hard at work at the 7th International Collaboration…
Mar 8, 2024, 15:14 | Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
Mar 7, 2024, 17:35 | Blog
Giselle Sholler: At the Annual Beat Childhood Cancer Research Consortium Conference we listened to breakthrough research that led us to create 5 new clinical trials
Giselle Sholler, Division Chief Pediatric Hematology/Oncology/BMT at Penn State Health Children’s Hospital, posted on LinkedIn:…
Mar 7, 2024, 16:59 | Insight
Vincent Rajkumar: Summary of drug approvals in relapsed myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a post on X: “Summary of…
Mar 4, 2024, 02:19 | Insight
Pashtoon Kasi: March is Colorectal Cancer Awareness Month. Best timing to kick off 4 clinical trials
Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X/Twitter:…
Mar 3, 2024, 16:42 | Blog
Vivek Subbiah: Thrilled to announce a groundbreaking - AstraZeneca and Sarah Cannon Docs collaboration
Vivek Subbiah shared a post on X: "Exciting News in Clinical Trials! Thrilled to announce…
Mar 1, 2024, 18:08 | Insight
Shankar Siva: For Kidney Cancer Awareness month The Lancet Oncology has a 50-day full link to TROG Cancer Research FASTRACK II
Quoting Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, on X/Twitter: ''For Kidney…
Mar 1, 2024, 17:25 | Insight
Marco Donia: The 'Influencers' of Cancer Immunotherapy do not affect immunotherapy outcomes
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn: "The…
Feb 29, 2024, 14:33 | Blog
Bettina Ryll: Another publication that leaves you as a patient between a rock and a hard place
Bettina Ryll, Founder of MPN Europe, shared on LinkedIn: "So another publication that leaves you…
Feb 28, 2024, 19:14 | Insight
Ramy Sedhom: Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability
Ramy Sedhom, Medical Oncologist and Director of Palliative Medicine at Penn Medicine, shared a post…
Feb 28, 2024, 14:20 | Blog
Arif Kamal: Cancer can affect anyone, but does not affect everyone equally
Arif Kamal, Chief Patient Officer at American Cancer Society, posted on LinkedIn: “Cancer can affect…
Feb 26, 2024, 10:05 | Blog
Misty Dawn Shields: Let’s work towards reducing operational burdens of trials on our patients!
Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, made the following post…
Feb 26, 2024, 00:02 | Blog
Ishwaria Subbiah: My 1st time in The White House!
Ishwaria Subbiah shared on LinkedIn: “My 1st time in The White House! Action-centered discussions with…
Feb 25, 2024, 15:31 | Opinion
Aaron Goodman: Until a trial demonstrates melflufen is superior to melphalan I see no reason to use it
Aaron Goodman shared a post on X: "Chemo is bad and toxic! Attach a peptide…
Feb 24, 2024, 17:10 | Blog
Bettina Ryll: How did we end up in a situation where we put clinical trials as a method before patients' lives?
Bettina Ryll, Founder of MPN Europe, shared on LinkedIn: "Working on my talk for the…
Feb 23, 2024, 18:03 | Blog
Vivek Subbiah: The development of armored CAR T-cells may enable CAR T to be efficacious against a broader range of malignancies
Vivek Subbiah recently shared on LinkedIn: "'CARs are sharpening their weapons'. The development of armored…
Feb 23, 2024, 10:51 | Blog
Amer Zeidan: Just an unbelievable cascade of news for magrolimab
Amer Zeidan shared on X: "Just an unbelievable cascade of news for magrolimab … Gilead…
Feb 22, 2024, 18:58 | Insight
Manni Mohyuddin: Read this paper carefully, then read it again
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on…
Feb 22, 2024, 17:59 | Blog
“The Immuno-Oncology Curve” with Dr. Steven O'Day – Guests are Dr. Joseph Grossman and Dr. Benny Johnson
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "In the latest episode…
Feb 20, 2024, 18:48 | Blog
The Pragmatica-Lung Study is considered a model for future cancer clinical trials - National Cancer Institute
Quoting National Cancer Institute on LinkedIn: "The Pragmatica-Lung Study is considered a model for future…
Feb 19, 2024, 18:08 | Blog
Stacy Hurt: Mapping “thought-to-action” leadership with our team in my new role
Stacy Hurt, Chief Patient Officer at Parexel, shared a post on her LinkedIn page: ''While…
Feb 14, 2024, 17:54 | Blog
This commentary by Donald Harvey et al. is a call to action for a concerted commitment to transform clinical trials - ACS Journal Cancer
ACS Journal Cancer posted on X: “This commentary by Donald Harvey et al. is a…
Feb 2, 2024, 12:20 | Insight
Erman Akkus: Targeting p53 in cancer. Is it promising?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Targeting p53 in cancer…
Jan 30, 2024, 15:51 | Insight
Manni Mohyuddin: It is often well known that the control arm is inferior prior to a single patient being enrolled on trial!
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, shared on X/Twitter:…
Jan 27, 2024, 22:56 | Blog
Antonio Passaro: This scientific journey has not only been immensely interesting but exceptionally fruitful
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Delighted to…
Jan 14, 2024, 15:31 | Insight
Talha Badar: Brief review of menin inhibitors in clinical trials.
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Jan 12, 2024, 23:05 | Insight
Yüksel Ürün: Radiographic and Clinical PFS as Surrogates for OS in Prostate Cancer shows promise in accelerating trials!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Jan 12, 2024, 23:00 | Insight
Iuliia Kovalenko: Tweetorial that explores the toxicity profile of combining immune checkpoint therapy with (VEGFi) in various cancer treatment
Iuliia Kovalenko, PGY-3 IM resident at UPMC Harrisburg, shared the following thread on X: "In…
Jan 9, 2024, 01:08 | Blog
SWOG's Impact Report for the year - SWOG Cancer Research Network
SWOG Cancer Research Network made the following post on Twitter: "Our SWOG Chair blog: SWOG's…
Jan 8, 2024, 10:12 | Blog
Sunil Verma: A great way to kick off 2024 by attending JPM2024
Sunil Verma, Global Head of Oncology of Medical AstraZeneca, shared a post on LinkedIn: ''A…
Jan 3, 2024, 20:27 | Opinion
Yüksel Ürün: Improving Clinical Trials for a Healthier Tomorrow
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 20, 2023, 12:00 | Insight
Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed
Elisa Agostinetto, Medical Research Fellow at Jules Bordet Institute in Brussels, recently posted X/Twitter: ''Blinded…
Dec 14, 2023, 23:38 | Blog
Charles Milrod: It was so much fun talking clinical trials in follicular lymphoma (FL)!
Charles Milrod, Hematology/Oncology fellow Brown University, made the following post on Twitter: "It was so…
Dec 11, 2023, 18:30 | Insight
Melvin Chua: This is an important consideration for current and future trials designs
Melvin Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation…
Dec 11, 2023, 17:54 | Insight
Talha Badar: ASH23, a few selected CML abstracts to watch out at this year ASH
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 9, 2023, 16:30 | Insight
Talha Badar: ASH23, a few selected MDS abstracts to watch out at this year ASH meeting
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 6, 2023, 16:05 | Blog
Christine M. Lovly: What does the Board of Directors for a prominent organization such as American Association for Cancer Research discuss at their meetings?
Christine M. Lovly posted on LinkedIn: "What does the Board of Directors for a prominent…
Dec 1, 2023, 22:12 | Blog
Samer Al Hadidi: Our study examined the prevalence and characteristics of subgroup analysis in oncology clinical trials
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on Twitter:…
Nov 27, 2023, 20:28 | Blog
Luigi Lorini: What is the role of ICIs in patients excluded from clinical trials?
Luigi Lorini, Medical Oncologist at Humanitas Research Hospital, made the following post on LinkedIn: "The…
Nov 22, 2023, 03:40 | Blog
Ishwaria Subbiah: Caring for our carers is at the heart of any cancer moonshot
Ishwaria Subbiah shared on LinkedIn: ''Honored to serve as the Medical Director for Professional Well-being…
Nov 21, 2023, 21:10 | Blog
Maria Garcia-Jimenez: Grateful for the amazing opportunity to be part of Winn Awards cohort 1
Maria Garcia-Jimenez, Director of Oncology Research at UCLA-Olive View, shared the following post by Rob…
Nov 18, 2023, 16:47 | Opinion
Rafael Fonseca: If you want to make biggest difference in medicine, I suggest you become a clinical investigator
Rafael Fonseca, Chief Innovation Officer at Mayo Clinic in Arizona, posted on X/Twitter. "FELLOWS: While…
Nov 18, 2023, 01:33 | Blog
Tatiana Prowell: There have been 3 cancer drug approvals in the last 24 hrs
Tatiana Prowell, Breast Cancer Scientific Lead at the Office of Hematology and Oncology Products, US…
Nov 12, 2023, 18:02 | Blog
Zisis Kozlakidis: It was a pleasure to see friends and colleagues at the AORTIC conference in Dakar, Senegal
Quoting Zisis Kozlakidis, Head of Laboratory Services and Biobanking at International Agency for Research on…
Nov 10, 2023, 17:10 | Blog
Arif Kamal: A leading barrier to accessing state-of-the-art treatment and clinical trials is housing
Arif Kamal, Chief patient officer for the American Cancer Society, posted on LinkedIn. "A leading…
Oct 25, 2023, 18:33 | Blog
Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are
Quoting Uwe Platzbecker, Head of Medical Department 1, Hematology and Cellular Therapy at Leipzig University,…
Oct 21, 2023, 23:53 | Blog
Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers
Peter Lebowitz, SVP, Global Oncology Therapeutic Area Head at Janssen/Johnson and Johnson, made the following…
Oct 11, 2023, 21:48 | Blog
Elsa Anagnostou: Pleased to see stage 1 of our ctDNA molecular response adaptive clinical trial in print.
Elsa Anagnostou, Director of Thoracic Oncology Biorepository and Associate Professor of Oncology at Johns Hopkins…
Oct 5, 2023, 17:42 | Insight
Vivek Subbiah: Still remember the 1st ever patient enrolled on the trial in the peak of the pandemic.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at The Sarah Cannon Research Institute, on…
Oct 2, 2023, 18:10 | Insight
Raffaele Colombo: ADC history.
Quoting Raffaele Colombo, Principal Scientists at Zyme Works on X/Twitter: “Maytansine was isolated in the…
Sep 26, 2023, 18:01 | Blog
Ishwaria Subbiah: Such a pleasure to help kickoff the Texas Society of Clinical Oncology’s 2023 Annual Meeting.
Ishwaria Subbiah shared the following on LinkedIn: ''Such a pleasure to help kickoff the Texas Society…
Sep 21, 2023, 19:06 | Blog
Sonja Loges: This weekend the DKFZ German Cancer Research Center was hosting the NCT 2nd National Conference Patients as Research Partners - entirely organized by patient experts.
Sep 21, 2023, 17:50 | Insight
TIGIT bispecific program is advancing in clinical trials for non-small cell lung and gastric cancers. - Agenus
Agenus shared on LinkedIn: “Our partner, Bristol Myers Squibb, unveiled exciting updates at their recent…
Sep 12, 2023, 14:33 | Blog
Shruti Patel: Had a great time co-leading the Clinical Trial Design work group at Stanford’s Think Tank on Diversity & Health Equity in Clinical Trials!
Shruti Patel, Chief Oncology Fellow at Stanford Medicine, posted the following on Twitter: "Had a…
Sep 12, 2023, 00:51 | Blog
Amy Comander: I am honored to be featured in this month's Boston Magazine, where I share the importance of access to clinical trials for the treatment of our patients with cancer, and how our team at the Mass General Cancer Center network sites provides such access to patients in the community.
Sep 7, 2023, 19:58 | Insight
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts...
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Sep 7, 2023, 19:47 | Insight
Chi-kong Li: Conducting clinical trials for children with cancer in Asia is challenging.
Quoting Chi-kong Li, a Research Professor at the Chinese University of Hong Kong, on LinkedIn: ''Conducting…
Sep 6, 2023, 00:26 | Drugs
Tian Zhang: Thanks Alliance for Clinical Trials in Oncology for supporting -- PDIGREE is the only phase 3 metastatic kidney cancer trial w/ supplied immunotherapies currently enrolling!
Sep 1, 2023, 23:35 | Opinion
Bree Burks: I hardly have words when I see the way my family member is tracking the next two years of her clinical trial visits.
Bree Burks, Vice President of Strategy, Site Solutions at Veeva Systems, posted the following on…
Aug 21, 2023, 18:21 | Opinion
Anne Marie Mercurio: For literally EVERYONE working in clinical trials, lose the word subject.
Anne Marie Mercurio, Patient research advocate, shared the following on twitter: "For literally EVERYONE working…
Aug 14, 2023, 20:07 | Blog
Tatiana McHardy: Over the last 20 years of my career at the ICR, I'm incredibly proud of my contribution in the development of drugs that are currently in clinical trials
Aug 11, 2023, 18:48 | Insight
Amer Zeidan: On behalf of an international panel, we issued a call-for-action to harmonize/unify WHO22 and ICC22 classifications for AML
On behalf of an international panel, we issued a call-for-action to harmonize/unify WHO22 & ICC22…
Aug 8, 2023, 18:54 | Blog
We have been able to bring novel state-of-the-art clinical trials to patients in the Tampa Bay region and beyond, many of which would not have access to trials otherwise - David Swoboda
Aug 8, 2023, 05:16 | Blog
Massive Bio, fueled by NCI/NIH support, is wielding the power of AI to match patients with clinical trials - Arturo Loaiza-Bonilla
Dare to know more: https://lnkd.in/eGD2J6Bw We stand on the precipice of a new era in cancer…
Aug 6, 2023, 17:11 | Blog
Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year - Paolo Tarantino
With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing…
Aug 6, 2023, 11:41 | Opinion
Good clinical practice does not mean endless and mindless tasks that no one knows why they exist aside from generating work and money for CROs - Amer Zeidan
If I am in charge of regulating trials i would cut down 50% of needless…
Aug 4, 2023, 19:54 | Blog
A new cornerstone paper by EORTC, EORTC Breast Cancer Group and Imaging groups - Icro Meattini
A new cornerstone paper by EORTC, EORTC Breast Cancer Group and Imaging groups. Designing clinical trials…
Aug 3, 2023, 08:06 | Blog
ASCO and AACR really show their commitment to mentoring new clinical investigators in the science - John Byrd
Congratulations to our ASCO/AACR 2023 Methods in Clinical Cancer Research Workshop scholars who spent 6…
Jul 30, 2023, 17:17 | Positive
Together, we can make a difference! - Vivek Subbiah
"If not us, then who? If not now, then when?” -John Lewis Let's deliver cutting…
Jul 29, 2023, 18:50 | Blog
All my appreciation for Naveen Pemmaraju for being a world leader in the field of BPDCN (yes 123 field !) and MPN - Nitin Jain
All my appreciation for Naveen Pemmaraju for being a world leader in the field of…
Jul 25, 2023, 16:47 | Societies
St. Baldrick’s is proud to announce 34 new grants to childhood cancer researchers at 23 institutions totaling $8.4 million - St. Baldrick's Foundation
It’s time for a work break because we got big news! Thanks to donors like…
Jul 25, 2023, 15:50 | Blog
This team tirelessly synthesized and tested over 10,000 derivatives, eventually identifying a compound with exceptional anti-cancer activity and no toxicity - Sendurai Mani
Jul 24, 2023, 16:18 | Blog
So great to spend the day with visionary NCI DIrector Monica Bertagnolli and so many leaders in clinical research - Neal Meropol
So great to spend the day with visionary NCI DIrector Monica Bertagnolli and so many leaders in…
Jul 23, 2023, 17:05 | Blog
ASCO expert panel chaired by Navneet Singh and Megan Daly has published an update on management of stage III NSCLC based on the ADAURA and KEYNOTE-671 trials - Navneet Singh
Jul 22, 2023, 20:34 | Positive
I’m running with Fred’s Team and I’m raising money for innovative cancer research at Memorial Sloan - Benoit Rousseau
TRAINING FOR MY FIRST MARATHON TO SUPPORT CANCER RESEARCH! I’m running with Fred’s Team and…
Jul 22, 2023, 19:34 | Blog
CRI congratulates SURGE Therapeutics on their completion of a $32 million Series B financing - Cancer Research Institute
CRI congratulates SURGE Therapeutics, led by former CRI CLIP Award Grantee Michael Goldberg, Ph.D, on their completion…
Jul 22, 2023, 18:35 | Stories
What from ASCO Annual Mtg ASCO23 should I know when I start my clinic on Monday? - Ishwaria Subbiah
A final tweak of the slides en route to Seattle for the 2023 Best of…
Jul 20, 2023, 17:26 | Societies
Join SGO's online forum for allied health professionals specializing in gynecologic oncology - SGO
Join SGO's online forum for allied health professionals specializing in gynecologic oncology. Members discuss various…
Jul 12, 2023, 19:09 | Blog
Led by Dr. Preet Chaudhary our cancer researchers are developing a new, improved type of CAR T-cell immunotherapy called Synthetic Immune Receptor (SIR-T) therapy
In a post by Caryn Lerman on Linkedin, it says, "Led by Dr. Preet Chaudhary, member…
Jul 10, 2023, 18:24 | Blog
Efforts to increase participation of older adults on cancer clinical trials must built on a foundation of comprehensive care for their unique needs - Ishwaria Subbiah
Efforts to increase participation of older adults (aged 65 years and above) on cancer clinical…
Jul 10, 2023, 14:59 | Positive
Today, we stand to celebrate the power of advocacy - Gloria Chinyere Okwu
The Launch of NATIONAL INSTITUTE FOR CANCER RESEARCH AND TREATMENT. NAF Conference Center, Abuja .…
Jul 6, 2023, 15:16 | Positive
2016-2019, I established and led a lung cancer program - Fredrick Chite Asirwa
2016-2019, I established and led a lung cancer program (kenya, TANZANIA, southafrica, Eswatini, Swaziland, Lesotho)…
All: 409 Posts: 301 - 400
Special Coverage